CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Net loss	$ (3,187,800)	$ (1,403,411)
Adjustments to reconcile net loss to cash provided by (used in) operating activities
Stock based compensation expense	148,736	124,599
Depreciation and amortization	1,600,060	1,593,584
Rent paid by common stock	0	244,000
(Gain) Loss on sale of assets	13,100	(9,701,834)
(Increase) Decrease in fair value of derivative liability	(920,672)	1,986,320
Amortization of debt discount and deferred costs	318,512	1,291,870
Changes in operating assets and liabilities
Accounts receivable	3,934,346	2,637,258
Inventory	(381,981)	(1,016,556)
Prepaid expenses	1,273,772	428,958
Accounts payable and accrued expenses	(1,322,370)	(3,770,626)
Deferred revenue	0	722,789
Other assets	(253,000)	0
Net cash provided by (used in) operating activities	1,222,703	(6,863,049)
Cash flows from investing activities
Acquisition of Acadiana	(320,700)	0
Purchase of fixed assets	(1,100,962)	(1,216,916)
Proceeds from sales of Bango assets	0	29,788,114
Costs related to sale of Bango assets	0	(10,792,446)
Establish escrow account - restricted cash	(1,952)	(1,500,000)
Proceeds from sale of fixed assets	62,594	20,900
Net cash provided by (used in) investing activities	(1,361,020)	16,299,652
Cash flows from financing activities
Payment of debt issuance costs	(1,656,350)	0
Line of credit (payments) proceeds, net	(1,818,744)	(1,193,664)
Proceeds from sale of Series C Preferred Stock	0	4,000,000
Proceeds from note payable	12,160,194	5,366,584
Payments on note payable	(10,241,622)	(16,592,492)
Net cash used in financing activities	(1,556,522)	(8,419,572)
Net change in cash and cash equivalents	(1,694,839)	1,017,031
Cash and cash equivalents at beginning of the period	1,701,435	765,364
Cash and cash equivalents at end of period	6,596	1,782,395
SUPPLEMENTAL INFORMATION
Cash paid for interest	260,352	474,573
Cash paid (received) for income tax expense (benefit)	0	(117,646)
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Accretion of discount on Series B and B-1 Preferred Stock	433,201	386,658
Dividends-in-Kind accrued on Series B and B-1 Preferred Stock	417,636	373,706
Return of common shares for sale escrow	1,109	0
Series A Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of preferred stock into common stock	30	120
Series B1 Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of preferred stock into common stock	119,440	$ 0
Dividends-in-Kind accrued on Series B and B-1 Preferred Stock	$ 276,144